Ruiz Gutierrez M, Bölükbaşı Ö, Alexe G, Kotini A, Ballotti K, Joyce C, et al. Therapeutic discovery for marrow failure with MDS predisposition using pluripotent stem cells. JCI Insight. 2019;5: pubmed publisher

Hayashi R, Ishikawa Y, Katayama T, Quantock A, Nishida K. CD200 facilitates the isolation of corneal epithelial cells derived from human pluripotent stem cells. Sci Rep. 2018;8:16550 pubmed publisher

Suila H, Pitkänen V, Hirvonen T, Heiskanen A, Anderson H, Laitinen A, et al. Are globoseries glycosphingolipids SSEA-3 and -4 markers for stem cells derived from human umbilical cord blood?. J Mol Cell Biol. 2011;3:99-107 pubmed publisher

Mitchell M, Grandizio C, Turan N, Requesens D. An induced pluripotent stem cell line (CIMRi001-A) from a Vici syndrome donor with a homozygous recessive c.1007A>G (p.Q336R) mutation in the EPG5 gene. Stem Cell Res. 2022;63:102833 pubmed publisher

Bi Y, Tu Z, Zhou J, Zhu X, Wang H, Gao S, et al. Cell fate roadmap of human primed-to-naive transition reveals preimplantation cell lineage signatures. Nat Commun. 2022;13:3147 pubmed publisher

Gill D, Parry A, Santos F, Okkenhaug H, Todd C, Hernando Herraez I, et al. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. elife. 2022;11: pubmed publisher

Houweling P, Coles C, Tiong C, Nielsen B, Graham A, McDonald P, et al. Generating an iPSC line (with isogenic control) from the PBMCs of an ACTA1 (p.Gly148Asp) nemaline myopathy patient. Stem Cell Res. 2021;54:102429 pubmed publisher

Ababneh N, Barham R, Al Kurdi B, Ali D, Sharar N, Al Hadidi S, et al. Generation of an induced pluripotent stem cell (iPSC) line (JUCTCi017-A) from a patient with limb-girdle muscular dystrophy (LGMD) due to a homozygous p.Lue287Ser fs14* mutation in the SGCB gene. Stem Cell Res. 2021;54:102358 pubmed publisher

Hohmann M, Habiel D, Espíndola M, Huang G, Jones I, Narayanan R, et al. Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF. JCI Insight. 2021;6: pubmed publisher

Leavens K, Liao C, Gagne A, Kishore S, Cardenas Diaz F, French D, et al. Generation of a double insulin and somatostatin reporter line, SCSe001-A-3, for the advancement of stem cell-derived pancreatic islets. Stem Cell Res. 2020;50:102112 pubmed publisher

Ababneh N, Al Kurdi B, Barham R, Ali D, Sharar N, Abuarqoub D, et al. Derivation of three human induced pluripotent stem cell lines (JUCTCi014-A, JUCTCi015-A, JUCTCi016-A) from mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue and Wharton's jelly samples. Stem Cell Res. 2020;49:102000 pubmed publisher

Ababneh N, Ali D, Barham R, Al Kurdi B, Sharar N, Al Hadidi S, et al. Establishment of a human induced pluripotent stem cell line, JUCTCi012-A, from multiple symmetric lipomatosis (MSL) patient carrying a homozygous Arg707Trp (c.2119C > T) mutation in the MFN2 gene. Stem Cell Res. 2020;48:101967 pubmed publisher

Ababneh N, Al Kurdi B, Ali D, Abuarqoub D, Barham R, Alzibdeh A, et al. Generation and characterization of induced pluripotent stem cell (iPSC) line (JUCTCi002-A) from a patient with ataxia with oculomotor apraxia type 1 (AOA1) harboring a homozygous mutation in the APTX gene. Stem Cell Res. 2020;48:101925 pubmed publisher

Döpper H, Horstmann M, Menges J, Bozet M, Kanber D, Steenpass L. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Stem Cell Res. 2020;45:101779 pubmed publisher

Bi Y, Tu Z, Zhang Y, Yang P, Guo M, Zhu X, et al. Identification of ALPPL2 as a Naive Pluripotent State-Specific Surface Protein Essential for Human Naive Pluripotency Regulation. Cell Rep. 2020;30:3917-3931.e5 pubmed publisher

Nur Patria Y, Lilianty J, Elefanty A, Stanley E, Labonne T, Bateman J, et al. Generation of a SOX9-tdTomato reporter human iPSC line, MCRIi001-A-2, using CRISPR/Cas9 editing. Stem Cell Res. 2019;42:101689 pubmed publisher

Menges J, Cremanns M, Steenpass L. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state. Stem Cell Res. 2019;39:101517 pubmed publisher

Simic M, Moehle E, Schinzel R, Lorbeer F, Halloran J, Heydari K, et al. Transient activation of the UPRER is an essential step in the acquisition of pluripotency during reprogramming. Sci Adv. 2019;5:eaaw0025 pubmed publisher

Li X, Dong T, Li Y, Wu F, Lan F. Generation of a human iPSC line from a patient with Marfan syndrome caused by mutation in FBN1. Stem Cell Res. 2019;36:101414 pubmed publisher

Maguire J, Gagne A, Gonzalez Alegre P, Davidson B, Shakkottai V, Gadue P, et al. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2019;34:101361 pubmed publisher

Schipper L, Kanber D, Steenpass L. Generation of heterozygous and homozygous hESC H9 sublines carrying inactivating mutations in RB1. Stem Cell Res. 2018;33:41-45 pubmed publisher

Neureiter A, Brändl B, Hiber M, Tandon R, Muller F, Steenpass L. Generation of an iPSC line of a patient with Angelman syndrome due to an imprinting defect. Stem Cell Res. 2018;33:20-24 pubmed publisher

Gagne A, Maguire J, Gandre Babbe S, Chou S, Tasian S, Loh M, et al. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160 pubmed publisher

Marrone L, Bus C, Schöndorf D, Fitzgerald J, Kübler M, Schmid B, et al. Generation of iPSCs carrying a common LRRK2 risk allele for in vitro modeling of idiopathic Parkinson's disease. PLoS ONE. 2018;13:e0192497 pubmed publisher

Gao Y, Wilson G, Bozaoglu K, Elefanty A, Stanley E, Dottori M, et al. Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease. Stem Cell Res. 2018;28:161-164 pubmed publisher

Steenpass L. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1. Stem Cell Res. 2017;25:270-273 pubmed publisher

Slamecka J, McClellan S, Wilk A, Laurini J, Manci E, Hoerstrup S, et al. Induced pluripotent stem cells derived from human amnion in chemically defined conditions. Cell Cycle. 2018;17:330-347 pubmed publisher

Xia H, Gilbertsen A, Herrera J, Racila E, Smith K, Peterson M, et al. Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis. J Clin Invest. 2017;127:2586-2597 pubmed publisher

Pashos E, Park Y, Wang X, Raghavan A, Yang W, Abbey D, et al. Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. Cell Stem Cell. 2017;20:558-570.e10 pubmed publisher

Bi X, Pashos E, Cuchel M, Lyssenko N, Hernandez M, Picataggi A, et al. ATP-Binding Cassette Transporter A1 Deficiency in Human Induced Pluripotent Stem Cell-Derived Hepatocytes Abrogates HDL Biogenesis and Enhances Triglyceride Secretion. EBioMedicine. 2017;18:139-145 pubmed publisher

Yang W, Liu Y, Slovik K, Wu J, Duncan S, Rader D, et al. Generation of iPSCs as a Pooled Culture Using Magnetic Activated Cell Sorting of Newly Reprogrammed Cells. PLoS ONE. 2015;10:e0134995 pubmed publisher

Chou S, Byrska Bishop M, Tober J, Yao Y, Vandorn D, Opalinska J, et al. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2012;109:17573-8 pubmed publisher